日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ovarian cancer-derived IL-4 promotes immunotherapy resistance

卵巢癌来源的IL-4促进免疫疗法耐药性

Gurkan Mollaoglu ,Alexander Tepper ,Chiara Falcomatà ,Hunter T Potak ,Luisanna Pia ,Angelo Amabile ,Jaime Mateus-Tique ,Noam Rabinovich ,Matthew D Park ,Nelson M LaMarche ,Rachel Brody ,Lindsay Browning ,Jia-Ren Lin ,Dmitriy Zamarin ,Peter K Sorger ,Sandro Santagata ,Miriam Merad ,Alessia Baccarini ,Brian D Brown

Chemical genetic control of cytokine signaling in CAR-T cells using lenalidomide-controlled membrane-bound degradable IL-7

利用来那度胺控制的膜结合可降解IL-7对CAR-T细胞中的细胞因子信号传导进行化学遗传控制

Michael C Kann ,Emily M Schneider ,Antonio J Almazan ,Isabel C Lane ,Amanda A Bouffard ,Valentina M Supper ,Hana N Takei ,Alexander Tepper ,Mark B Leick ,Rebecca C Larson ,Benjamin L Ebert ,Marcela V Maus ,Max Jan

Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide

来那度胺控制的可逆ON和OFF开关嵌合抗原受体

Max Jan ,Irene Scarfò ,Rebecca C Larson ,Amanda Walker ,Andrea Schmidts ,Andrew A Guirguis ,Jessica A Gasser ,Mikołaj Słabicki ,Amanda A Bouffard ,Ana P Castano ,Michael C Kann ,Maria L Cabral ,Alexander Tepper ,Daniel E Grinshpun ,Adam S Sperling ,Taeyoon Kyung ,Quinlan L Sievers ,Michael E Birnbaum ,Marcela V Maus ,Benjamin L Ebert

Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies

Avadomide 诱导血液系统恶性肿瘤中 ZMYM2 融合癌蛋白的降解

Aline Renneville, Jessica A Gasser, Daniel E Grinshpun, Pierre M Jean Beltran, Namrata D Udeshi, Mary E Matyskiela, Thomas Clayton, Marie McConkey, Kaushik Viswanathan, Alexander Tepper, Andrew A Guirguis, Rob S Sellar, Sophie Cotteret, Christophe Marzac, Véronique Saada, Stéphane De Botton, Jean-Ja

Bone marrow-specific loss of ABI1 induces myeloproliferative neoplasm with features resembling human myelofibrosis

ABI1 的骨髓特异性缺失会诱发具有类似人类骨髓纤维化特征的骨髓增生性肿瘤

Anna Chorzalska, John Morgan, Nagib Ahsan, Diana O Treaba, Adam J Olszewski, Max Petersen, Nathan Kingston, Yan Cheng, Kara Lombardo, Christoph Schorl, Xiaoqing Yu, Roberta Zini, Annalisa Pacilli, Alexander Tepper, Jillian Coburn, Anita Hryniewicz-Jankowska, Ting C Zhao, Elena Oancea, John L Reagan,

Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-κB pathways in a model of chronic myeloid leukemia

在慢性粒细胞白血病模型中,Tpl2 的过度表达与伊马替尼耐药性以及 MEK-ERK 和 NF-κB 通路的激活有关

Anna Chorzalska, Nagib Ahsan, R Shyama Prasad Rao, Karim Roder, Xiaoqing Yu, John Morgan, Alexander Tepper, Steven Hines, Peng Zhang, Diana O Treaba, Ting C Zhao, Adam J Olszewski, John L Reagan, Olin Liang, Philip A Gruppuso, Patrycja M Dubielecka

Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia

长期暴露于甲磺酸伊马替尼可下调慢性粒细胞白血病模型中的 Hippo 通路并激活 YAP

Anna Chorzalska, Javier Flores Kim, Karim Roder, Alexander Tepper, Nagib Ahsan, R Shyama Prasad Rao, Adam J Olszewski, Xiaoqing Yu, Dmitry Terentyev, John Morgan, Diana O Treaba, Ting C Zhao, Olin Liang, Philip A Gruppuso, Patrycja M Dubielecka